Home 30+ Industry Leaders Share Insights on Truly Deployable Medical AI Large Models

30+ Industry Leaders Share Insights on Truly Deployable Medical AI Large Models

May 04, 2025 08:00 CST Updated 08:00
创新资产.png


The emergence of DeepSeek has enabled global investors to recognize the opportunities in Chinese assets and technology companies. With the advent of DeepSeek’s technology and the development of domestically produced large language models, China’s AI foundation model capabilities are gradually strengthening, significantly increasing the likelihood of practical application deployment. This shift means that investment opportunities in AI applications will no longer be confined to short-term hype but will instead focus on identifying projects with genuine implementation capabilities.


To help Chinese medical AI projects unlock greater value and capture more market opportunities,VCBeat on May 9-10At the 2025 VBEF Future Healthcare & Pharma Top 100 Exhibition (VBEF) held at the Suzhou International Expo Center,Co-hosted with Tansuoziben Capital: “Forum on Innovative Applications of Large AI Models in Healthcare”, inviting guests from AI healthcare technology companies across China, AI investors, digitalization departments of pharmaceutical companies, and themed industrial parks to attend the conference and jointly promote the development of large AI models in the healthcare industry.


Overall Forum on Innovative Applications of Large Medical AI ModelsThe schedule spans 1.5 days., to maximize the depth, breadth, cutting-edge nature, and resource richness of the topics discussed.


AI大模型.jpg


Find premium medical AI assets and qualified buyers at VCBeat VBEF


✦ Multinational pharmaceutical companies and listed enterprises present, with thematic sharing from 30+ leading Chinese large model companies


On the afternoon of the 9th, the co-organizersProbe CapitalPioneering the sharing of insights on how large AI models empower medical innovation,SenseTime Medical, Jianhai Technology, Quanzhen Medicine, Lingxi Medical, Olive Branch HealthAs an industry pioneer, sharing large model applications based on practical experience; roundtable session,Probe Capital, Jianhai Technology, Quanzhen Medicine, Lingxi Medical, and Fengrui CapitalJointly Explore the Key Elements and Pathways for the Innovative Implementation of Large Medical Models;Puhua Capital, Newell Capital, Labpioneer, Yiduoyun Health, Shuidi Pharmaceutical Services, and Yuanyi CapitalWe will conduct exploratory efforts to break through bottlenecks in value validation, data ecosystem development, and innovative payment mechanisms for large language models.


All day on May 10,Ryan Harper, Head of China Product Pipeline Strategy and Digital Innovation at Roche PharmaceuticalsDelivering Remarks at the Forum,Meinian Onehealth, Roche Pharmaceuticals Digital Division, JD Health, Neusoft Medical, Tencent HealthDelivering the latest corporate strategy presentation on medical AI, andHuamei Haolian, Weimei Health, Deshi Bio, Maide Intelligence, Nanda Feite, Lejian Health, Langye Medicaldozens of innovative AI companies shared their respective practical achievements,Bohe Innovation CenterProviding an Incubator’s Perspective: A Deep Dive into Large Medical Models


Institute for Prevention and Control of Chronic Non-communicable Diseases, Guangdong Provincial Center for Disease Control and Prevention; Guangzhou Municipal Center for Disease Control and PreventionPresenting practical cases of regional large models.


✦ Sharing Real-World Cases of the Hottest Application Scenarios: Directly Addressing the Challenges of Large Model Deployment


At this forum, we will fully witnessCase Studies on the Application of Large Medical Models in Various Subfields, including specialist/general practice diagnosis and treatment, primary healthcare, medical imaging, intelligent diagnosis and treatment, post-consultation health management, and insurance risk control,Challenges Truly Faced During Implementation, and the pathways through which different entities address challenges.


✦ Report Released: Providing a Value Coordinate System for Capital and Industrial Layouts of Large Medical AI Models


At this forum,"New Quality Productive Forces: White Paper on the Integrated Innovation Practices of Large Models in Healthcare Scenarios"A major release summarizing the challenges and opportunities, practices and trends in scenario-based applications of large medical models, providing the industry with authentic references for the practical implementation of large medical models.


✦ In terms of breadth, aggregate resources from all stakeholders in the medical AI industry to promote efficient industrial collaboration.


To foster in-depth exchange and collaboration among stakeholders in the medical AI industry, VCBeat is concurrently hosting a series of N+ activities alongside VBEF, including closed-door government-enterprise meetings, premium asset promotion sessions, and innovative product launch events.By adopting a tripartite model of “exhibition + forum + trading,” we facilitate deep connections between high-quality assets and global capital, local industrial chains, and end-user medical institutions, thereby helping China’s innovative healthcare and pharmaceutical assets bridge the gap from “innovation capability” to “productive capacity.”


The Exhibition Facilitates Diverse Matchmaking:2025 VBEF Special Exhibition Area DesignCenter Stage (Themed Roadshows, Product Launches), Innovative Product Showcase (Product Demos, Case Studies)Innovative Assets Poster Exhibition (TOP 100 Investment Landscape, Resource Matchmaking)Three Major Value Domains: Accelerating the Value Fission of High-Quality Assets in China’s Medical and Pharmaceutical Innovation through Innovative Models and Efficient Mechanisms.


Forum Decoding Trends:2 Main Forums, 4 Featured Forums, and 20+ Thematic Forums comprehensively cover the hot sectors of high-quality innovative assets in China’s healthcare and pharmaceutical industries. Over 300 industry leaders, academicians, experts, and corporate executives discuss growth poles in China’s healthcare industry, precisely identifying growth drivers for high-quality assets.


High-Efficiency Transaction Scenarios:Exhibiting companies can engage directly with international buyers, overseas distributors, and supply chain partners. Through on-site negotiations and demand-matching sessions, they can swiftly secure business opportunities in cross-border cooperation, technology introduction, and product distribution, thereby facilitating the integration of China’s high-quality innovative medical and pharmaceutical assets into the global industrial chain.

Registration Open to Industry Partners, engage in direct communication and negotiate cooperation with innovative enterprises.


AI大模型二维码.png

Tipping Point, Seizing the Initiative


官网-日程.png

会刊 0427印刷版(1)_07.png

官网1-广告位.png


Exhibition Overview


Exhibition Name:2025 VBEF Future Healthcare & Pharma Top 100 Expo

Exhibition Time:May 9–10, 2025

Venue:China · Suzhou · International Expo Center

Exhibition Scale:16,000+ visits


Organizational Structure


会刊 0425(2)_041.png